Header graphic for print
FDA Life News and Trends Impacting the FDA and Life Science Industry

Category Archives: Risk Management

Subscribe to Risk Management RSS Feed

Abbott Secures Preliminary Injunction in Gray Market Case

Posted in Drug Quality and Security Act, Drug Supply Chain Security Act, Intellectual Property, Litigation, Medical Devices, Risk Management

Medical equipmentOn November 6, 2015, Abbott Laboratories and its diabetes care units secured a preliminary injunction against multiple pharmacies, distributors and associated individuals engaged in the sale of gray market Abbott FreeStyle diabetes test strips designed for sale internationally to U.S. Continue Reading